Harada A, Anno T, Kaku K, Kaneto H
Endocrinol Diabetes Metab Case Rep. 2025; 2025(1).
PMID: 39903574
PMC: 11825166.
DOI: 10.1530/EDM-24-0035.
Lee J, Yoon K
Endocrinol Metab (Seoul). 2025; 40(1):57-63.
PMID: 39814030
PMC: 11898318.
DOI: 10.3803/EnM.2024.2193.
Sakai Y, Wakao N, Matsui H, Osada N, Watanabe T, Watanabe K
Spine Surg Relat Res. 2024; 8(6):583-590.
PMID: 39659381
PMC: 11625720.
DOI: 10.22603/ssrr.2024-0025.
Imura H
Proc Jpn Acad Ser B Phys Biol Sci. 2024; 100(9):500-507.
PMID: 39522972
PMC: 11635088.
DOI: 10.2183/pjab.100.036.
Takao T, Suka M, Nishikawa M, Yanagisawa H, Ishii T
Fam Pract. 2024; 42(2).
PMID: 39446604
PMC: 11809247.
DOI: 10.1093/fampra/cmae054.
Sulfonylurea prescription patterns in elderly patients with type 2 diabetes mellitus: A comprehensive analysis of real-world data from pharmacies in Japan.
Yamazaki M, Takebe T, Hosokawa M, Saika T, Nakao Y, Ikeda S
J Diabetes Investig. 2024; 15(11):1604-1613.
PMID: 39226073
PMC: 11527806.
DOI: 10.1111/jdi.14302.
Disruption of insulin receptor substrate 2 (IRS2) causes non-obese type 2 diabetes with β-cell dysfunction in the golden (Syrian) hamster.
Hirose M, Inoue K, Matoba S, Tatebe T, Tokita S, Dodo Y
Sci Rep. 2024; 14(1):17450.
PMID: 39134590
PMC: 11319448.
DOI: 10.1038/s41598-024-67513-9.
Sex-specific association of circulating Isthmin-1 with isolated post-challenge hyperglycemia.
Fan J, He J, Zhu J, Yang J, Ju J, Huang J
Front Endocrinol (Lausanne). 2024; 15:1394190.
PMID: 39119006
PMC: 11306075.
DOI: 10.3389/fendo.2024.1394190.
Comparison of medication persistence and adherence in type 2 diabetes using a once-weekly regimen of DPP-4 inhibitor compared with once-daily and twice-daily regimens: a retrospective cohort study of Japanese health insurance claims data.
Miwa T, Yoshida S, Nakajima A, Koto R, Nishimura R
Diabetol Int. 2024; 15(3):483-494.
PMID: 39101196
PMC: 11291815.
DOI: 10.1007/s13340-024-00714-9.
The integrated incretin effect is reduced by both glucose intolerance and obesity in Japanese subjects.
Hamasaki A, Harada N, Muraoka A, Yamane S, Joo E, Suzuki K
Front Endocrinol (Lausanne). 2024; 15:1301352.
PMID: 38966210
PMC: 11222327.
DOI: 10.3389/fendo.2024.1301352.
Associations between time in range and insulin secretory capacity in Japanese patients with type 2 diabetes.
Tanaka K, Okada Y, Uemura F, Tanaka Y
Sci Rep. 2024; 14(1):12910.
PMID: 38839813
PMC: 11153530.
DOI: 10.1038/s41598-024-63678-5.
Age-wise examination of the association of obesity based on body mass index and waist circumference with metabolic diseases in comprehensive health checkup participants.
Yamamoto Y, Ikeue K, Kanasaki M, Yamakage H, Satoh-Asahara N, Masuda I
Obes Sci Pract. 2024; 10(2):e746.
PMID: 38501152
PMC: 10946448.
DOI: 10.1002/osp4.746.
Gut insulin action protects from hepatocarcinogenesis in diabetic mice comorbid with nonalcoholic steatohepatitis.
Soeda K, Sasako T, Enooku K, Kubota N, Kobayashi N, Ikushima Y
Nat Commun. 2023; 14(1):6584.
PMID: 37852976
PMC: 10584811.
DOI: 10.1038/s41467-023-42334-y.
Dipeptidyl peptidase-4 inhibitors reduce the incidence of first cardiovascular events in Japanese diabetic patients.
Soejima H, Ogawa H, Morimoto T, Okada S, Matsumoto C, Nakayama M
Heart Vessels. 2023; 38(11):1371-1379.
PMID: 37522902
DOI: 10.1007/s00380-023-02291-4.
[Efficacy of treatment with glucagon-like peptide receptor agonists-1 in Asian patients with type 2 diabetes mellitus].
Khamnueva L, Andreeva L
Probl Endokrinol (Mosk). 2023; 69(2):38-46.
PMID: 37448270
PMC: 10204790.
DOI: 10.14341/probl13245.
Associations of Clusters of Cardiovascular Risk Factors with Insulin Resistance and Β-Cell Functioning in a Working-Age Diabetic-Free Population in Kazakhstan.
Saruarov Y, Nuskabayeva G, Gencer M, Sadykova K, Zhunissova M, Tatykayeva U
Int J Environ Res Public Health. 2023; 20(5).
PMID: 36900929
PMC: 10001384.
DOI: 10.3390/ijerph20053918.
Obesity and risk for its comorbidities diabetes, hypertension, and dyslipidemia in Japanese individuals aged 65 years.
Yamada T, Kimura-Koyanagi M, Sakaguchi K, Ogawa W, Tamori Y
Sci Rep. 2023; 13(1):2346.
PMID: 36759688
PMC: 9911391.
DOI: 10.1038/s41598-023-29276-7.
Age-Related Sex Differences in Glucose Tolerance by 75 g Oral Glucose Tolerance Test in Japanese.
Yoshida A, Kimura T, Tsunekawa K, Shoho Y, Yanagawa Y, Araki O
Nutrients. 2022; 14(22).
PMID: 36432554
PMC: 9698682.
DOI: 10.3390/nu14224868.
Role of insulin action in the pathogenesis of diabetic complications.
Tsuchiya K
Diabetol Int. 2022; 13(4):591-598.
PMID: 36117926
PMC: 9477992.
DOI: 10.1007/s13340-022-00601-1.
Increase in glycemic set point, alongside a decrease in waist circumference, in the non-diabetic population during the Japanese National Intervention Program for metabolic syndrome: A single-center, large-scale, matched-pair analysis.
Sugiyama T, Yamada Y, Ito Y, Mineo R, Iwamoto R, Tamba S
PLoS One. 2022; 17(8):e0268450.
PMID: 35947600
PMC: 9365144.
DOI: 10.1371/journal.pone.0268450.